We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics

Download Mobile App

CTK Biotech’s Single-Use COVID-19 Antigen Self-Test Receives CE Mark

By LabMedica International staff writers
Posted on 04 Nov 2021
Print article
Image: OnSite COVID-19 Ag Self Test (Photo courtesy of CTK Biotech, Inc.)
Image: OnSite COVID-19 Ag Self Test (Photo courtesy of CTK Biotech, Inc.)

CTK Biotech, Inc. (Poway, CA, USA) has obtained the CE mark for its OnSite COVID-19 Ag Self Test and will begin shipping the new test to the countries that accept the CE mark this month.

The OnSite COVID-19 Ag Self Test is a single-use lateral flow immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasal swab specimens from individuals suspected of COVID-19. The test is designed for use with self-collected samples within the first seven days post-onset of symptoms, as an aid in identifying SARS-CoV-2 infection. The easy-to-use test screens for COVID-19 in 15 to 20 minutes and uses nasal swab for ease of use and minimizing discomfort. The OnSite COVID-19 Ag Self-Test comes with two individually sealed test kits.

With over 20 years in infectious disease diagnostics, CTK has manufactured a line-up of professional use COVID-19 diagnostic tools. In addition to the OnSite COVID-19 Ag Self Test, the company also offers the OnSite COVID-19 Ag Rapid Test that detects the presence of antigens from the SARS-CoV-2 virus, namely the viral Nucleocapsid Protein (NP). The OnSite COVID-19 Ag Rapid Test can detect the NP mutants with mutations from the UK, South Africa, and Brazil variants.

In August this year, the company had launched the Aridia COVID-19 Real-Time PCR Test for the specific and qualitative detection of the novel coronavirus SARS-CoV-2, responsible for COVID-19, in respiratory specimens. The test targets the conserved regions of the SARS-CoV-2 ORF1ab and N genes using specific primers and fluorescently labeled probes. The test can detect the SARS-CoV-2 UK, South Africa, Brazil, California, Nigeria, and India (Delta) variants. Furthermore, as the Aridia COVID-19 Real-Time PCR Test detects two SARS-CoV-2 targets, its performance is less susceptible to the effects of variants than tests designed to detect a single target.

Related Links:
CTK Biotech, Inc. 

Gold Supplier
SARS-CoV-2 S-IgG Antibody Assay
Lumipulse G SARS-CoV-2 S-IgG
Silver Supplier
COVID-19 Ag Self Test
OnSite COVID-19 Ag Self Test
Silver Supplier
Automated RPR Syphilis Test
Automated RPR Test Kit
Tuberculosis (TB) Test
QIAreach QuantiFERON-TB

Print article



view channel
Image: Atellica Solution (Photo courtesy of Siemens Healthineers)

Siemens Introduces New Intelligent, Integrated IVD Solutions Virtually at EUROMEDLAB 2021

Siemens Healthineers (Erlangen, Germany) introduced new intelligent, integrated IVD solutions virtually at the XXIV IFCCEFLM European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab... Read more


view channel
Image: The Luminex 200 Instrument System sets the standard for multiplexing, providing the ability to perform up to 100 different tests in a single reaction volume on a flow cytometry-based platform (Photo courtesy of Luminex Corp)

Inflammatory Cytokines Measured in Infants Born to Preterm Preeclamptic Mothers

Preeclampsia is both a vascular and inflammatory disorder. The pathophysiology of preeclampsia is complex and rooted in the interplay between maternal and placental factors with the key characteristics... Read more


view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more


view channel
Image: The Ventana BenchMark Ultra autostainer is for cancer diagnostics with automation and the test menu include IHC, ISH, and FITC tests (Photo courtesy of Ventana Medical System)

Specific Biomarker Investigated for Triple-Negative Breast Cancer Diagnosis

Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression and comprises a heterogeneous... Read more


view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more


view channel

Global Lateral Flow Assay Market to Reach Nearly USD 6.5 Billion by 2031 Due to Surge in Demand for Rapid POC Testing

The global lateral flow assay market is projected to grow at a CAGR of around 5% from USD 3.7 billion in 2020 to over USD 6.4 billion by 2031, driven by the growing adoption of home-based lateral flow... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.